Carl Zeiss Meditec

OverviewSuggest Edit

Carl Zeiss Meditec is a company providing medical technology solutions. It operates in two business areas: Ophthalmology and Microsurgery. The Ophthalmology business area is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic systems for ophthalmology, and the Surgical Ophthalmology unit combines the activities in the field of ophthalmic implants and disposables. The Microsurgery business area offers surgical microscopes and visualization solutions for ear, nose, and throat surgery.
TypePublic
Founded2002
HQJena, DE

Latest Updates

Employees (est.) (Sept 2021)3,531(+8%)
Revenue (FY, 2021)€1.6 B(+24%)
Share Price (May 2022)€110.7
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Carl Zeiss Meditec

Markus Weber

Markus Weber

President and Chief Executive Officer
Justus Felix Wehmer

Justus Felix Wehmer

Member of the Management Board and Chief Financial Officer
Jan Willem de Cler

Jan Willem de Cler

Member of the Management Board and Chief Human Resources Officer
Show more

Carl Zeiss Meditec Office Locations

Carl Zeiss Meditec has offices in Jena, Berlin, München, Oberkochen and in 16 other locations
Jena, DE (HQ)
Göschwitzer Str. 51-52
Berlin, DE
Max-Dohrn-Straße 8-10
München, DE
Kistlerhofstraße 75
Oberkochen, DE
Rudolf-Eber-Straße 11
Suzhou, CN
Suzhou Industrial Park 333 Xingpu Rd
Le Pecq, FR
60 Rte de Sartrouville
Show all (20)

Carl Zeiss Meditec Financials and Metrics

Carl Zeiss Meditec Revenue

Carl Zeiss Meditec's revenue was reported to be €1.65 b in FY, 2021
EUR

Revenue (FY, 2021)

1.6b

Gross profit (FY, 2021)

1.0b

Net income (FY, 2021)

237.5m

EBITDA (FY, 2021)

435.2m

EBIT (FY, 2021)

373.6m

Market capitalization (13-May-2022)

10.4b

Closing stock price (13-May-2022)

110.7

Cash (30-Sept-2021)

7.4m

EV

10.7b
Carl Zeiss Meditec's current market capitalization is €10.4 b.
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

1.3b1.5b1.3b1.6b

Cost of goods sold

(539.2m)(579.1m)(529.5m)(618.0m)

Gross profit

741.7m880.3m805.9m1.0b

R&D expense

(159.6m)(173.3m)(218.8m)(232.1m)
Half Year
EURH1, 2019H1, 2020H1, 2021

Revenue

667.2m714.9m767.4m

Cost of goods sold

(271.3m)(289.4m)(299.4m)

Gross profit

395.9m425.6m470.4m

R&D expense

(78.5m)(105.5m)(111.6m)
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Cash

6.7m22.6m5.2m7.4m

Accounts Receivable

192.3m205.8m165.2m185.9m

Prepaid Expenses

13.0m15.5m11.1m13.7m

Inventories

248.1m268.3m286.4m286.4m
Half Year
EURH1, 2019H1, 2020H1, 2021

Cash

10.4m14.9m8.3m

Accounts Receivable

173.8m170.1m164.9m

Prepaid Expenses

6.5m1.9m

Inventories

270.7m317.4m274.1m
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

126.2m160.6m123.4m237.5m

Depreciation and Amortization

31.3m48.4m60.4m61.6m

Inventories

(11.8m)(11.3m)(28.4m)18.0k

Accounts Payable

921.0k14.7m(25.2m)52.7m
Half Year
EURH1, 2019H1, 2020H1, 2021

Net Income

58.9m65.0m101.5m

Depreciation and Amortization

22.9m27.8m29.9m

Inventories

(17.6m)(50.6m)11.0m

Accounts Payable

3.5m(661.0k)33.1m
EURFY, 2018

EV/EBITDA

18 x

EV/EBIT

20.5 x

EV/CFO

22 x

Revenue/Employee

420.2k
Show all financial metrics

Carl Zeiss Meditec Operating Metrics

FY, 2016H1, 2017FY, 2017H1, 2018FY, 2018H1, 2019

Order Volume

€162.7 m€175.7 m€165.3 m€155.8 m€152.9 m€151.8 m

Patent Families

800850850

Trademarks and Trademark Applications

630610530

R&D Centers

252525

Carl Zeiss Meditec Acquisitions / Subsidiaries

Company NameDateDeal Size
IanTECHDecember 14, 2018€204.56 m
Veracity InnovationsAugust 18, 2017€12.53 m
Ophthalmic Laser EnginesFebruary 24, 2017€19.15 m
Atlantic S.A.S.
Carl Zeiss Meditec Asset Management Verwaltungsgesellschaft mbH
Carl Zeiss Meditec Co. Ltd.
Carl Zeiss Meditec Digital Innovations LLC
Carl Zeiss Meditec France S.A.S.
Carl Zeiss Meditec Iberia S.A.
Carl Zeiss Meditec Inc.
Show more

Carl Zeiss Meditec Revenue Breakdown

Embed Graph

Carl Zeiss Meditec revenue breakdown by business segment: 76.3% from OPHTHALMIC SYSTEMS and 23.7% from MICROSURGERY

Carl Zeiss Meditec Online and Social Media Presence

Embed Graph

Carl Zeiss Meditec News and Updates

VSY Biotechnology BV and Carl Zeiss Meditec AG Settled Their Legal Disputes

AMSTERDAM, Feb. 15, 2019 /PRNewswire/ -- VSY Biotechnology BV and Carl Zeiss Meditec AG jointly announced that both companies resolved their legal and patent disputes with respect to Tri-ED 611. The companies agreed not to disclose the terms of the settlement. www.vsybiotechnology.com...

Global Dermatology Treatment Devices Market 2019 – 2025 | Alma Lasers, Ambicare Health Ltd, Amd Global, Biolitec Ag, Carl Zeiss Meditec, Cutera, Cynosure, Ellipse A/S, Fei Company, Fotofinder

The report covers key drivers, limitations and opportunities in the global Dermatology Treatment Devices market. It also has details of marketing channels, traders and distributors and regional import and export analysis. In summary, this market will be of benefit to end users and will create a suc…

Intraocular Lenses Market growth 2019 – 2025 - Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG

The report also includes competitive profiling of key players operating in the Intraocular Lenses market around the globe. The important strategies adopted by leading players, their overview, financials, business segments, and key developments have been identified in the research report. Posted via …

Microsurgery Market Growth Analysis Till 2026 By Top Key Players Carl Zeiss Meditec AG, Hu-Friedy Mfg. Co., LLC, MicroSurgical Technology, S&T AG, Aesculap, Inc.

High prevalence of cancer, ophthalmic disease, and chronic diseases has increased the market growth. According to the report from the Cancer Research U.K. in 2012, around 14.1 million cases of cancer were registered, globally. Posted via Industry Today. Follow us on Twitter @IndustryToday

Technology aspects on Global Photochromic lenses Market Business Growth Statistics and Key Carl Zeiss Meditec AG, Corning Incorporated, Essilor International S.A., HOYA Corporation, Forecast to 2019-2025

Photochromic lenses are optical lenses that darken on exposure to specific types of light of sufficient intensity, most commonly ultraviolet (UV) radiation. They are principally used in eyeglasses that are dark in bright sunlight, but clear in low ambient light conditions. Photochromic lenses filter…

Extremity Reconstruction Market Volume Analysis, Segments, Value Share; Booming Growth in globally manufacturers like A.R.C. Laser, Abbott Medical Optics, Alcon, Bausch & Lomb Incorporated, Calmar Laser, Carl Zeiss Meditec

The Global Extremity Reconstruction Market Report includes a comprehensive analysis of the present market. The report starts with the basic Extremity Reconstruction Market overview and then goes into each and every detail. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Carl Zeiss Meditec Frequently Asked Questions

  • When was Carl Zeiss Meditec founded?

    Carl Zeiss Meditec was founded in 2002.

  • Who are Carl Zeiss Meditec key executives?

    Carl Zeiss Meditec's key executives are Markus Weber, Justus Felix Wehmer and Jan Willem de Cler.

  • How many employees does Carl Zeiss Meditec have?

    Carl Zeiss Meditec has 3,531 employees.

  • What is Carl Zeiss Meditec revenue?

    Latest Carl Zeiss Meditec annual revenue is €1.6 b.

  • What is Carl Zeiss Meditec revenue per employee?

    Latest Carl Zeiss Meditec revenue per employee is €466.4 k.

  • Who are Carl Zeiss Meditec competitors?

    Competitors of Carl Zeiss Meditec include NIDEK, HOYA and W. L. Gore & Associates.

  • Where is Carl Zeiss Meditec headquarters?

    Carl Zeiss Meditec headquarters is located at Göschwitzer Str. 51-52, Jena.

  • Where are Carl Zeiss Meditec offices?

    Carl Zeiss Meditec has offices in Jena, Berlin, München, Oberkochen and in 16 other locations.

  • How many offices does Carl Zeiss Meditec have?

    Carl Zeiss Meditec has 20 offices.